A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer
Sagar Sardesai, Mohamed Badawi, Ewa Mrozek, Evan Morgan, Mitch Phelps, Julie Stephens, Lai Wei, Mahmoud Kassem, Yonghua Ling, Maryam Lustberg, Daniel Stover, Nicole Williams, Rachel Layman, Raquel Reinbolt, Jeffrey VanDeusen, Mathew Cherian, Michael Grever, William Carson, Bhuvaneswari Ramaswamy, Robert Wesolowski
Dive into the research topics of 'A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer'. Together they form a unique fingerprint.